ViPHS Videosupport In the PreHospital Stroke chain; step 2
|Coordinator||VÄSTRA GÖTALANDS LÄNS LANDSTING - Neurosjukvården|
|Funding from Vinnova||SEK 500 000|
|Project duration||September 2017 - October 2018|
|Call||Medtech4Health:Innovators in Healthcare 2017|
Purpose and goal
The aim of the project was to provide a link in the more comprehensive project ViPHS - part of step 2 of totally 3. In this part of step 2, basic technical issues and tests for the clinical trials should be answered, and a final technology platform defined and tested. Furthermore, an ethics application and the approval thereof should be handled. All input for the next phase are available at the end of the project, all tests have been carried out and ethics approval is in place. Practically, this means that the project has been able to move seamlessly into the limited clinical tests.
Expected results and effects
The project has created knowledge about technology solutions, choice of components like cameras, routers, tablets, etc., as well as mobile coverage where clinical trials are conducted. It has been found that there is no need for so-called bonding technology in the 4g network. Instead, it increases complexity and creates unwanted delays. The coverage is such that this redundancy is not needed to get desired performance. This is important knowledge for both ViPHS, as for other projects, and will be reported in the "ViPHS recommendation". The results are now used in the clinical trials.
Planned approach and implementation
The technical tests have been carried out in 3 settings: lab bench, passenger car and test ambulance. These settings and the experiments carried out have been excellent complements to each other, and the value of being able to dispose a dedicated test ambulance equipped exactly as those to be included in the clinical trials cannot be underestimated. The project has been divided into work packages with dedicated managers. These and the project manager constitutes the project management. One of the work packages handled ethics approval. This approach has worked impeccably.